Technical Analysis for AZRX - AzurRx BioPharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Historical AZRX trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | -4.64% | |
Inside Day | Range Contraction | -4.64% | |
Wide Bands | Range Expansion | -4.64% | |
Crossed Above 20 DMA | Bullish | -14.79% | |
Wide Bands | Range Expansion | -14.79% | |
Hammer Candlestick | Bullish | -2.70% | |
Lizard Bullish | Bullish Day Trade Setup | -2.70% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | -2.70% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -2.70% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Lower Bollinger Band Support | 1 day ago | |
Down 10% | 1 day ago | |
Down 5% | 1 day ago | |
Down 3% | 1 day ago | |
Down 2 % | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
Azurrx Biopharma, Inc. is a biopharmaceutical company. It focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. The company's product pipeline consists of MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency and AZX1101, a recombinant enzyme for the prevention of hospital-acquired C.difficile infections. Azurrx Biopharma, Inc. is headquartered in New York City.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Gastrointestinal Molecular Biology Insulin Gastrointestinal Disease Gastrointestinal Diseases Synthetic Biology Recombinant Proteins Lipase Recombinant Dna Exocrine Pancreatic Insufficiency Treatment Of Gastrointestinal Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Gastrointestinal Molecular Biology Insulin Gastrointestinal Disease Gastrointestinal Diseases Synthetic Biology Recombinant Proteins Lipase Recombinant Dna Exocrine Pancreatic Insufficiency Treatment Of Gastrointestinal Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.63 |
52 Week Low | 0.3709 |
Average Volume | 9,442,969 |
200-Day Moving Average | 0.95 |
50-Day Moving Average | 1.27 |
20-Day Moving Average | 1.64 |
10-Day Moving Average | 1.65 |
Average True Range | 0.22 |
ADX | 35.93 |
+DI | 28.29 |
-DI | 24.54 |
Chandelier Exit (Long, 3 ATRs ) | 1.38 |
Chandelier Exit (Short, 3 ATRs ) | 1.92 |
Upper Bollinger Band | 1.93 |
Lower Bollinger Band | 1.35 |
Percent B (%b) | 0.16 |
BandWidth | 35.42 |
MACD Line | 0.07 |
MACD Signal Line | 0.13 |
MACD Histogram | -0.0581 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.70 | ||||
Resistance 3 (R3) | 1.69 | 1.61 | 1.65 | ||
Resistance 2 (R2) | 1.61 | 1.54 | 1.61 | 1.64 | |
Resistance 1 (R1) | 1.52 | 1.50 | 1.48 | 1.53 | 1.62 |
Pivot Point | 1.44 | 1.44 | 1.42 | 1.44 | 1.44 |
Support 1 (S1) | 1.35 | 1.37 | 1.31 | 1.36 | 1.26 |
Support 2 (S2) | 1.27 | 1.33 | 1.27 | 1.24 | |
Support 3 (S3) | 1.18 | 1.27 | 1.23 | ||
Support 4 (S4) | 1.19 |